NEW YORK (GenomeWeb) – Scientists have used whole-exome sequencing to detail the genomic changes that drove relapse in patients with acute lymphoblastic leukemia (ALL).

Cancers such as leukemia are not a homogeneous disease, but a jumble of different dividing cancer cells, called clones, with distinctive sets of mutations. While chemotherapy might kill almost all the clones, some might escape therapy, leaving them to multiply and cause relapse.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.